Search

A recent report from Tokyo University of Pharmacy and Life Sciences explores the role of a protein called TMEM106B in a white matter disorder known as hypomyelinating leukodystrophy 16 (HLD16). The researchers found that a specific mutation in TMEM106B, called p.Asp252Asn, affects the distribution of the protein in oligodendroglial cells, which are involved in myelin production in the central nervous system. This mutation also impairs cell differentiation and decreases signaling through the lysosome-resident mechanistic target of rapamycin (mTOR). However, treatment with hesperetin, a citrus flavonoid, was able to restore the cellular phenotypes induced by the TMEM106B mutant protein. These findings provide insights into the pathological mechanisms underlying HLD16 and potential avenues for amelioration. [Extracted from the article]

Researchers at the University of Minho in Braga, Portugal have conducted a study on the anticancer activity of benzo[a]phenoxazine compounds. The researchers focused on breast and colorectal cancer, which have high prevalence and mortality rates. They found that three compounds from their library showed selective activity against cancer cells, reducing cell proliferation, survival, and migration. These compounds targeted lysosomes in cancer cells, leading to cell death. The study suggests that these compounds have potential as inducers of lysosomal membrane permeabilization for cancer therapy. [Extracted from the article]

A recent report from Nanjing Medical University in China provides new information about cytoplasmic and nuclear receptors and their role in renal fibrosis. The study found that glutamate dehydrogenase (GDH) 1, an enzyme involved in glutamine metabolism, is downregulated in kidney tissues of individuals with kidney disease and animal models of chronic kidney disease (CKD). Inhibiting GDH1 or using a GDH1 inhibitor called R162 improved renal fibrosis in both in vivo and in vitro models. The researchers also discovered that GDH1 interacts with peroxisome proliferator-activated receptor gamma (PPAR gamma) and inhibits its transcriptional activity, which contributes to fibrosis. Suppressing GDH1 or using R162 treatment could prevent renal fibrosis by enhancing PPAR gamma's transcriptional activity and controlling lipid accumulation and redox balance. [Extracted from the article]

A recent study published in Cancer Weekly explores the role of cyclin C (Ccnc) in pancreatic development and cancer initiation. The study found that Ccnc is necessary for autophagic gene transcription in mouse embryonic fibroblasts. In vivo experiments showed that pancreatic ablation of Ccnc resulted in phenotypes similar to autophagy deficient models, but with more severe outcomes. The study suggests that inhibiting cyclin C-Cdk8/Cdk19 proteasome activity could be a potential target for treating pancreatic neoplasms. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of epigenetic changes in oncogenic transformation and drug resistance. The researchers focused on the regulation of lysosomal exocytosis, which is involved in drug resistance, and hypothesized that epigenetic modifier drugs (epidrugs) could inhibit lysosomal exocytosis and serve as potential therapeutics. They screened approximately 150 epidrugs and found that two type I PRMT inhibitors, MS023 and GSK3368715, inhibited lysosomal exocytosis and showed synergy with other drugs sequestered in lysosomes. The study suggests that type I PRMT inhibitors could be used as therapeutic agents in cancer treatment. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A recent report from researchers at the Department of Food Science and Nutrition in Nara, Japan, explores the potential use of caveolae, cellular structures involved in cholesterol metabolism and lipid transport, as a therapeutic target for cognitive dysfunction associated with neurodegenerative diseases. The researchers suggest that modulating autophagy/mitophagy through the alteration of glucagon-like peptide-1 (GLP-1) and N-methyl-d-aspartate (NMDA) receptor signaling could offer a novel approach to preventing and alleviating cognitive dysfunction. The study proposes that targeting GLP-1 and NMDA receptors at caveolae sites may be crucial for the treatment of cognitive dysfunctions and could potentially modify the progression of Alzheimer's disease. [Extracted from the article]

A study conducted by researchers at Anhui Normal University in Wuhu, China, has explored the use of nanoplatforms for targeted phototherapy in cancer treatment. The researchers designed and synthesized bisBODIPY nanoparticles that can generate reactive oxygen species and exhibit superior photothermal conversion efficiencies. These nanoparticles demonstrated lysosomal targeting and effective tumor ablation in cellular and murine models, suggesting their potential for precision tumor therapy. The study was funded by the National Natural Science Foundation of China and the Natural Science Foundation of Anhui Province. [Extracted from the article]

Researchers at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York have published a report on the mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Autophagy is a process that helps recycle cellular components and eliminate damaged organelles and proteins. Neurons are particularly vulnerable to disruptions in autophagy-lysosomal function, especially as the brain ages. Mutations in genes that regulate autophagy and lysosomal functions can lead to various neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and frontotemporal dementia. The study emphasizes the importance of understanding the role of autophagy-lysosomal function in neuronal health and disease. [Extracted from the article]

A recent study conducted at Zhejiang University in China explored the role of UNC13B in regulating the sensitivity of Wilms' tumor cells to the chemotherapy drug doxorubicin. Wilms' tumor is a malignant neoplasm that has shown resistance to doxorubicin, leading to the need for higher dosages and decreased sensitivity. The study found that UNC13B expression levels were elevated in Wilms' tumor cells compared to normal kidney cells, and its knockdown resulted in increased apoptosis levels upon doxorubicin treatment. The researchers suggest that UNC13B could be a potential target for optimizing chemotherapy in Wilms' tumor and other cancers with high UNC13B expression. [Extracted from the article]

A recent study conducted by researchers at the New Jersey Institute of Technology explored the effects of phthalates, a class of endocrine disrupting chemicals found in everyday products, on ovarian function. The researchers focused on granulosa cells, which play a crucial role in hormone production and supporting the development of oocytes. The study found that exposure to phthalates disrupted the expression of genes related to lipid metabolism and peroxisome proliferator-activated receptor (PPAR) signaling in granulosa cells. These findings suggest that phthalates can interfere with ovarian function by targeting granulosa cells and affecting important biological processes. [Extracted from the article]

A recent study conducted at Yale University has provided new insights into the role of lysosomes in coordinating macromolecule degradation and regulating cell growth and metabolism. The study focused on the role of TANK-binding kinase 1 (TBK1) in modulating lysosomal responsiveness to nutrients. The researchers found that TBK1 is recruited to lysosomes in response to elevated amino acid levels, where it phosphorylates Rab7 on serine 72. This phosphorylation is critical for relieving Rab7-mediated inhibition of amino acid-dependent mTORC1 activation. The study suggests that dysregulation of this lysosomal TBK1 signaling could contribute to the pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. [Extracted from the article]

Researchers from the Center for Interdisciplinary Sciences in Kolkata, India have developed a fluorescent probe called LD-VP that can assess the viscosity and polarity of cells. This probe can provide dual-channel images to monitor cellular microviscosity and lipid droplets within live cells. The probe is chemically inert and safe for use in live cell imaging. The researchers believe that this tool has the potential to visualize physiological abnormalities or pathological conditions. [Extracted from the article]

Scientists at The Hospital for Sick Children have discovered a novel recycling mechanism in mitochondria, the "powerhouse of the cell." Mitochondria are responsible for generating energy and maintaining cell health. The researchers found that damaged folds called cristae in the inner membrane of mitochondria can be removed and broken down by lysosomes, preventing harm from spreading to the rest of the mitochondria and the cell. This discovery could have implications for the diagnosis and treatment of conditions characterized by mitochondrial dysfunction, such as cancer and neurodegenerative diseases. [Extracted from the article]

The article reports on recent research from China-based Zhejiang Science Technical University regarding the development of nitrogen-doped carbon quantum dots (NCQDs) for cancer detection. It describes how these fluorescent probes, which are sensitive to pH changes, offer a new method for distinguishing cancer cells from normal cells by exploiting variations in lysosomal pH levels.

According to a preprint abstract from biorxiv.org, researchers have discovered a cell survival strategy that involves the formation of a giant unilocular vacuole (GUVac) in the cytoplasm of cells when their actin cytoskeleton is disrupted due to loss of attachment to the extracellular matrix (ECM). Time-lapse imaging and electron microscopy showed that large vacuoles accumulated and subsequently coalesced to form a GUVac. This process, which resembles macropinocytosis, relies on F-actin depolymerization and the recruitment of septin proteins. The induction of GUVac formation after loss of matrix attachment was found to confer resistance to anoikis, a type of programmed cell death. [Extracted from the article]

A patent has been issued for wearable and automated ultrasound therapy devices and methods. The patent describes a device that can be used to treat kidney disease, induce pulmonary rehabilitative effects, treat peripheral artery disease, and treat deep vein thrombosis. The device includes ultrasound transducer units that generate and deliver ultrasound therapy to the target therapy area of the user. It also has a communications bus to receive health status data from a physiological sensor, memory for ultrasound therapy instructions, and a processor to process the instructions and control the ultrasound therapy. The device aims to provide a portable, cost-effective, and efficient solution for these medical conditions. [Extracted from the article]

A study conducted in Hunan, China, investigated the role of lysosome-related genes in breast cancer prognosis and immunity. The researchers used transcriptome data and gene sets to identify two subtypes of breast cancer. They successfully identified an 11-gene signature that can predict survival outcomes in breast cancer patients and found differences in immune status between patients with different prognoses. The study suggests that immunotherapy may be more effective for low-risk patients and identifies potential targeted drugs for this group. The research provides valuable insights for breast cancer clinical immunotherapy. [Extracted from the article]

A recent study conducted on the bacterial pathogen Chlamydia trachomatis has identified a potential target for destabilizing the parasitophorous vacuole, a structure that protects the bacteria from host defenses. The study found that a mutant deficient in the effector CpoS displayed an increased reliance on host cellular ceramide synthesis to compensate for its diminished ability to acquire sphingolipids. By disrupting ceramide synthesis, the researchers were able to further destabilize the vacuoles and prevent the defensive host cell death response. This study sheds light on the role of the vacuole as a refuge for the bacteria and provides potential directions for future therapeutic interventions. [Extracted from the article]

The article focuses on a Phase 1 clinical trial evaluating the safety and efficacy of pacritinib for treating VEXAS (Vacuoles, E1 Ubiquitin-Activating Enzyme, X-linked, Autoinflammatory, Somatic) syndrome. Topics include the rationale for using pacritinib as a treatment, the study's design and dosing regimen, and the criteria for patient enrollment and dose adjustments.

A recent report from Ohio State University Wexner Medical Center discusses the mechanisms of lysosomal tubulation and sorting driven by LRRK2, a protein associated with Parkinson's disease. The researchers found that lysosomes, which are cellular structures involved in waste disposal, can adaptively remodel their membranes in response to damage. They also discovered a process called LYTL, in which damaged lysosomes generate tubules that are sorted into mobile vesicles and interact with healthy lysosomes. The study highlights the role of LRRK2 kinase activity and the recruitment and phosphorylation of certain RAB GTPases in this process. [Extracted from the article]

A patent application has been filed for the use of certain agents in preventing the transition from acute to chronic pain. The method involves administering these agents to patients between 1 and 7 days after a traumatic pain event, such as physical injury, invasive surgery, or acute illness. The agents mentioned include NAAA inhibitors, FAAH inhibitors, PPARa agonists, PEA, acetyl-L-carnitine, a-lipoic acid, and olesoxime. This method could potentially help prevent chronic pain in various patient populations, including those with cancer or diabetes. [Extracted from the article]

A study conducted by researchers from the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University in China explores the role of lysosomes in osteoclasts and their potential implications for the treatment of bone diseases. Lysosomes are involved in various cellular processes and their dysfunction has been linked to the development of diseases. The study aims to elucidate the mechanisms of lysosomal biogenesis and function in osteoclasts, specifically in relation to differentiation, bone resorption, and autophagy. The researchers also discuss the potential therapeutic implications of targeting lysosomes in the treatment of bone metabolic disorders. [Extracted from the article]

A study conducted by researchers at Hangzhou Normal University in Zhejiang, China, has investigated the potential anticancer effects of ss-Elemene (ss-ELE) on non-small cell lung cancer (NSCLC). The study focused on the role of TFEB, a master regulator of lysosome biogenesis, in the degradation of glutathione peroxidase 4 (GPX4) and the induction of ferroptosis, a promising strategy for cancer therapy. The researchers found that ss-ELE can bind to TFEB, activate lysosome and TFEB, and increase the degradation of GPX4, leading to ferroptosis in EGFR wild-type NSCLC cells. This study suggests that TFEB-mediated GPX4 degradation could be a novel strategy for ferroptosis induction and NSCLC therapy. [Extracted from the article]

The article reports that Janssen Pharmaceutica NV has been granted a patent for a pharmaceutical composition that includes combinations of positive allosteric modulators or orthosteric agonists of the metabotropic glutamatergic receptor subtype 2, specifically targeting the treatment of epilepsy. It states that the patent details the invention of a combination of synaptic vesicle protein 2A (SV2A) ligands, such as levetiracetam and brivaracetam, which are used to treat epilepsy.

A patent application has been submitted by researchers from the University of Toledo for a compound that can induce cell death in cancer cells through nonapoptotic mechanisms such as methuosis or autophagy. The compound, which includes a 4-pyridyl group linked to a heterocyclic group, has shown promising results in inhibiting cell growth and sensitizing resistant cancer cells to cytotoxicity. It can be used to treat various types of cancer, including colon, lung, ovarian, prostate, breast, brain, and pancreatic cancer. The compound also activates lysosomes in cells and can be used to study biological events. [Extracted from the article]

A recent study conducted at Inje University in South Korea investigated the role of chaperone-mediated autophagy (CMA) in sciatic nerve injuries. The researchers used a mouse model and performed immunofluorescence analysis to observe the expression of LAMP2A, a marker for CMA. RNA sequencing and bioinformatics analysis were also conducted to identify hub genes associated with LAMP2A. The study found that CMA may play a significant role in sciatic nerve injuries through mRNA splicing. This research provides valuable insights into the molecular mechanisms involved in peripheral nerve injuries. [Extracted from the article]

A recent report from Osaka University in Japan discusses the importance of Rab6, a small GTPase, in the regulation of intracellular vesicular trafficking and neuronal polarization. The researchers found that Rab6-mediated polarized transport of synaptic vesicle precursors (SVPs) is crucial for the establishment of neuronal polarity and brain formation. In their study, they observed that mice with a double knockout of Rab6a/b exhibited severe dysplasia of the neocortex and cerebellum, as well as impaired axonal extension and loss of axon-dendrite polarity. These findings contribute to our understanding of the mechanisms involved in neuronal development and brain function. [Extracted from the article]

According to a preprint abstract, researchers have discovered that depletion of endomembrane reservoirs is a major factor in phagocytic appetite exhaustion in macrophages. During phagocytosis, macrophages form a phagocytic cup around a particle, which then fuses with endosomes and lysosomes to digest the particle. However, when macrophages reach their phagocytic capacity, they experience a reduction in surface membrane in-folding, membrane tension, and cortical F-actin, as well as a depletion of endosomes and lysosomes. This depletion of endomembrane pools contributes to phagocytic fatigue, although other processes may also be involved. The research has not yet undergone peer review. [Extracted from the article]

A recent report from the University of the Chinese Academy of Sciences in Shanghai, China, explores the role of cholesterol metabolites in the tumor microenvironment and their impact on macrophages. The researchers discovered that the expression of cholesterol-25-hydroxylase (Ch25h) is induced by interleukin-4 (IL-4) and interleukin-13 (IL-13), leading to the accumulation of 25-hydroxycholesterol (25HC). This accumulation of 25HC in lysosomes competes with cholesterol for binding to GPR155, inhibiting the kinase mTORC1 and activating AMPKa, which results in metabolic reprogramming and immunosuppressive macrophages. Targeting Ch25h could enhance anti-tumor efficacy by improving T cell numbers and activation. [Extracted from the article]

Researchers from Shenyang Pharmaceutical University in China have conducted a study on the effects of Gastrodin (GAS) on the degradation of mutant huntingtin protein (mHtt) in Huntington's disease (HD). The study found that GAS promoted the degradation of mHtt by activating the ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway (ALP). GAS also prevented mHtt-induced neuronal damage in PC12 cells and increased grip strength in transgenic mice. The findings suggest that GAS could be a potential therapeutic agent for HD. Further research is needed to determine the dose-response relationship of GAS on mHtt inhibition. [Extracted from the article]

This article discusses a study on the malaria parasite Plasmodium falciparum and its egress pathway from infected red blood cells. The researchers found that the phosphatase PP1 plays a crucial role in this process by controlling the rounding-up of the parasitophorous vacuole, a step necessary for egress. PP1 also regulates the homeostasis of the second messenger cGMP, which is involved in downstream calcium signaling. The study provides new insights into the regulation of the egress pathway and the role of PP1 in Plasmodium falciparum infections. Please note that this article is a preprint and has not yet undergone peer review. [Extracted from the article]

Researchers at Baylor University College of Medicine have made new findings in the field of Pain and Central Nervous System. They have discovered that synaptic vesicle cycle disorders, which are caused by pathogenic variants in presynaptic proteins, can lead to a range of neurological symptoms such as intellectual disability, epilepsy, movement disorders, cerebral visual impairment, and psychiatric symptoms. The most common disorder in this category is STXBP1 encephalopathy, which is caused by mutations in the STXBP1 gene. The researchers found that haploinsufficiency of STXBP1 in GABAergic/glycinergic neurons leads to developmental delay, epilepsy, and various cognitive and psychiatric deficits, while haploinsufficiency in glutamatergic neurons results in a different set of cognitive and seizure phenotypes. These findings suggest that targeting specific neurotransmitter systems could potentially modulate disease phenotypes. [Extracted from the article]

A study conducted by researchers at Chongqing University in China has found that enhancing the activity of a protein called Rab7 by inhibiting the expression of another protein called Tbc1d5 can improve the process of mitophagy, which is the removal of damaged mitochondria, in Alzheimer's disease (AD) models. Mitochondrial dysfunction is known to exist in the brains of individuals with AD, and the removal of damaged mitochondria is crucial for disease progression. The study showed that knocking down Tbc1d5 increased the activity of Rab7, promoted the fusion of lysosomes and autophagosomes, improved mitophagy, and led to improvements in the morphology of hippocampal neurons and behavior in AD mice. These findings provide new insights into potential therapeutic targets for AD by targeting mitophagy. [Extracted from the article]

A recent study conducted at Wenzhou Medical University in Zhejiang, China has developed a novel lysosome-targeted photosensitizer/photoredox catalyst for cancer therapy. The cyclometalated Ir(III) complex IrL demonstrated excellent phosphorescence properties and the ability to generate single oxygen and oxidize 1,4-dihydronicotinamide adenine dinucleotide (NADH) under light irradiation. These activities were enhanced under acidic conditions, making them promising for light-activated tumor therapy in acidic lysosomes and tumor microenvironments. The research also investigated the photocytotoxicity of IrL and its tumor-killing ability in a mouse model. This study provides a strategy for developing lysosome-targeted photosensitizers/photoredox catalysts to overcome hypoxic tumors. [Extracted from the article]

Researchers at The Hospital for Sick Children have discovered that inflammation in immune cells may contribute to severe symptoms in lysosomal storage diseases (LSDs), a group of rare genetic conditions. LSDs affect approximately one in 7,700 live births worldwide and often result in progressive neurodegeneration. The role of macrophages in the immune system and LSDs was previously unknown, but this new research has identified that macrophage inflammation may play a role in LSD symptoms. The researchers suggest that reducing inflammation could potentially improve or prevent symptoms in children with LSDs by blocking certain molecules involved in the inflammatory response. [Extracted from the article]

A recent study conducted at the Affiliated Hospital of Qingdao University in China focused on bioinformatics and its potential applications in understanding moyamoya disease (MMD). MMD is a rare cerebrovascular condition that poses significant clinical challenges. The researchers used gene expression data from the Gene Expression Omnibus (GEO) repository to identify differentially expressed genes (DEGs) associated with MMD. They employed various algorithms and machine learning techniques to identify potential diagnostic genes and validated their findings in an independent cohort. The study identified EPDR1, DENND3, and NCSTN as potential biomarkers for MMD and highlighted the involvement of various immune cells in the disease's pathogenesis. [Extracted from the article]

A recent study conducted at Rush University Medical Center in Chicago, Illinois, has found that the muscle-building supplement beta-hydroxy beta-methylbutyrate (HMB) stimulates the maturation of oligodendroglial progenitor cells (OPCs) to oligodendrocytes. This is significant because oligodendrocytes are responsible for myelination in the central nervous system, and multiple sclerosis (MS) is characterized by the progressive loss of myelin. The study suggests that increasing the maturation of OPCs to oligodendrocytes may have therapeutic benefits for MS. The research found that HMB activates peroxisome proliferator-activated receptor alpha (PPAR alpha) in OPCs, which then binds to the promoter of myelin-specific genes to stimulate gene transcription and increase the level of myelin-specific proteins. [Extracted from the article]

New research conducted at the University of Texas MD Anderson Cancer Center in Houston has identified a chromosome 3q amplicon that plays a crucial role in secretory regulation in cancer cells. The amplicon encodes multiple Golgi-resident proteins, including GOLIM4 and ATP2C1, which coordinate cargo loading, Golgi membrane bending, and vesicle scission. Disrupting this protein complex inhibits the progression of 3q-amplified malignancies. Additionally, the study found that manganese treatment can degrade GOLIM4 and interrupt prosurvival autocrine loops, thereby inhibiting the progression of 3q-amplified malignancies. The findings suggest that functional cooperativity between coamplified genes drives heightened secretion and a targetable secretory addiction in these types of malignancies. [Extracted from the article]

A recent study conducted by researchers at Zhejiang University School of Medicine explores the use of biomimetic vesicles for targeted drug delivery in the treatment of leukemia. The researchers developed vesicles by infusing hematopoietic stem and progenitor cell (HSPC) membrane with liposomes, which were found to migrate to the bone marrow of leukemic mice. These vesicles demonstrated superior binding affinity to leukemia cells and effectively inhibited proliferation, induced apoptosis and differentiation of leukemia cells, and decreased the number of leukemia stem cells. The study provides a promising method for targeting bone marrow and treating leukemia. [Extracted from the article]

A recent study conducted by researchers from PSL Research University in Paris, France, explores the role of mechanical forces and caveolae in various pathophysiological contexts. The study highlights how cells detect and respond to mechanical forces through mechanosensors located at the plasma membrane, specifically caveolae. These organelles not only protect the cell membrane but also regulate mechanotransduction. The findings suggest that understanding the interactions between mechanical forces and caveolae could lead to new therapeutic strategies and diagnostic biomarkers. [Extracted from the article]